MRVIMARAVAI LIFESCIENCES HOLDIN...

Nasdaq maravai.com


$ 9.43 $ 0.23 (2.45 %)    

Tuesday, 17-Sep-2024 13:22:56 EDT
QQQ $ 473.28 $ -2.69 (-0.57 %)
DIA $ 416.64 $ -1.35 (-0.32 %)
SPY $ 562.63 $ -2.51 (-0.44 %)
TLT $ 100.96 $ -0.43 (-0.42 %)
GLD $ 236.94 $ -1.04 (-0.44 %)
$ 9.14
$ 9.20
$ 9.43 x 200
$ 9.53 x 400
$ 9.11 - $ 9.50
$ 4.52 - $ 11.56
1,810,531
na
2.31B
$ 0.88
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 02-29-2024 12-31-2023 10-K
4 11-08-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 02-28-2023 12-31-2022 10-K
8 11-04-2022 09-30-2022 10-Q
9 08-05-2022 06-30-2022 10-Q
10 05-06-2022 03-31-2022 10-Q
11 03-01-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-11-2021 06-30-2021 10-Q
14 05-12-2021 03-31-2021 10-Q
15 03-22-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 maravai-lifesciences-holdings-on-sept-10-amended-existing-credit-agreement-to-extend-maturity-date-of-revolving-credit-facility-by-five-years

-Reuters

 wells-fargo-initiates-coverage-on-maravai-lifesciences-with-overweight-rating-announces-price-target-of-10

Wells Fargo analyst Brandon Couillard initiates coverage on Maravai LifeSciences (NASDAQ:MRVI) with a Overweight rating and ...

 wall-street-gains-ground-as-consumer-sentiment-improves-gold-hits-record-highs-boosting-mining-stocks-whats-driving-markets-friday

Wall Street edged slightly higher on Friday, with major equity indices showing modest gains at midday in New York.

Core News & Articles

- Reuters Citing Sources 

 rbc-capital-reiterates-outperform-on-maravai-lifesciences-maintains-15-price-target

RBC Capital analyst Conor McNamara reiterates Maravai LifeSciences (NASDAQ:MRVI) with a Outperform and maintains $15 price t...

 morgan-stanley-downgrades-maravai-lifesciences-to-equal-weight-lowers-price-target-to-10

Morgan Stanley analyst Tejas Savant downgrades Maravai LifeSciences (NASDAQ:MRVI) from Overweight to Equal-Weight and lowers...

 goldman-sachs-maintains-neutral-on-maravai-lifesciences-raises-price-target-to-8

Goldman Sachs analyst Matthew Sykes maintains Maravai LifeSciences (NASDAQ:MRVI) with a Neutral and raises the price target ...

 ubs-maintains-neutral-on-maravai-lifesciences-raises-price-target-to-11

UBS analyst Dan Brennan maintains Maravai LifeSciences (NASDAQ:MRVI) with a Neutral and raises the price target from $8.5 to...

 maravai-lifesciences-q2-sales-73400m-beat-71634m-estimate

Maravai LifeSciences (NASDAQ:MRVI) reported quarterly sales of $73.400 million which beat the analyst consensus estimate of $71...

 goldman-sachs-maintains-neutral-on-maravai-lifesciences-lowers-price-target-to-7

Goldman Sachs analyst Matthew Sykes maintains Maravai LifeSciences (NASDAQ:MRVI) with a Neutral and lowers the price target ...

 baird-maintains-outperform-on-maravai-lifesciences-raises-price-target-to-10

Baird analyst Catherine Schulte maintains Maravai LifeSciences (NASDAQ:MRVI) with a Outperform and raises the price target f...

 maravai-lifesciences-q1-2024-adj-eps-002-beats-003-estimate-sales-64179m-beat-60548m-estimate

Maravai LifeSciences (NASDAQ:MRVI) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION